Galactorrhea Probably Related with Switching from Osmotic-release Oral System Methylphenidate (MPH) to Modified-release MPH: An Adolescent Case
Clinical Psychopharmacology and Neuroscience
;
: 282-284, 2017.
Artículo
en Inglés
| WPRIM
| ID: wpr-152977
ABSTRACT
Galactorrhea, as an adverse effect of psychotropic medications, usually develops due to high dose of antipsychotics. Selective serotonin reuptake inhibitors (SSRIs) have also been reported to be related to galactorrhea. To the best of our knowledge, no previous study reported galactorrhea with methylphenidate (MPH) use. Hereby, we report a case of an adolescent girl who developed galactorrhea after increasing his modifed-release oral MPH to 50 mg/day while under treatment of sertraline and very low dose haloperidol.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Antipsicóticos
/
Inhibidores Selectivos de la Recaptación de Serotonina
/
Sertralina
/
Galactorrea
/
Haloperidol
/
Metilfenidato
Límite:
Adolescente
/
Femenino
/
Humanos
/
Embarazo
Idioma:
Inglés
Revista:
Clinical Psychopharmacology and Neuroscience
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS